DSpace Fukushima Medical University

福島県立医科大学学術成果リポジトリ = Fukushima Medical University Repository >
福島医学会 = The Fukushima Society of Medical Science >
Fukushima Journal of Medical Science >
Vol.66 (2020) >

このアイテムの引用には次の識別子を使用してください: http://ir.fmu.ac.jp/dspace/handle/123456789/1358

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_66_p148.pdf294.94 kBAdobe PDFダウンロード
タイトル: Reduction in anxiety during treatment with exercise and duloxetine is related to improvement of low back pain-related disability in patients with non-specific chronic low back pain
著者: Onda, Akira
Kimura, Masashi
誌名/書名: Fukushima Journal of Medical Science
巻: 66
号: 3
開始ページ: 148
終了ページ: 155
発行日: 2020年
抄録: Background:Non-invasive treatment is generally recommended for patients with non-specific chronic low back pain (CLBP). However, the impact of combination therapy with physical exercise and a serotonin-norepinephrine reuptake inhibitor has not been clarified in patients with non-specific CLBP. This study assessed the efficacy of combination treatment with exercise and duloxetine on non-specific CLBP and aimed to identify factors that contributed to improvement of LBP-induced disability. Methods:This prospective study was conducted on consecutive outpatients with non-specific CLBP. Patients received a supervised home-based exercise program and duloxetine administration for 15 weeks. The Roland-Morris Disability Questionnaire (RDQ), Numerical Rating Scale (NRS), Hospital Anxiety and Depression Scale (HADS), and Pain Catastrophizing Scale (PCS) were assessed at baseline and 15 weeks. Multiple logistic regression modeling was used to identify factors associated with an improvement in RDQ. Results:Forty-two patients were enrolled. Overall, scores on the RDQ, NRS, and PCS (total score, magnification, helplessness) were significantly reduced at 15 weeks (p < 0.01 for all). An improvement of disability was confirmed in 22 patients (52%). A higher HADS depression score before and after the intervention was significantly associated with a lack of improvement in disability (p < 0.01). Further, a reduction in HADS anxiety score over 15 weeks was a significant factor associated with an improvement in disability (odds ratio:1.99;95% CI:1.26-3.65). Conclusions:Supervised exercise plus duloxetine resulted in favorable outcomes and an improvement of LBP-related disability in approximately 50% of patients. A reduction in anxiety over treatment was associated with the improved disability.
出版者: The Fukushima Society of Medical Science
出版者(異表記): 福島医学会
本文の言語: eng
このページのURI: http://ir.fmu.ac.jp/dspace/handle/123456789/1358
本文URL: http://ir.fmu.ac.jp/dspace/bitstream/123456789/1358/1/FksmJMedSci_66_p148.pdf
ISSN: 0016-2590
2185-4610
DOI: 10.5387/fms.2020-22
PubMed番号: 33298637
関連ページ: https://doi.org/10.5387/fms.2020-22
権利情報: © 2020 The Fukushima Society of Medical Science. This article is licensed under a Creative Commons [Attribution-NonCommercial-ShareAlike 4.0 International] license.
権利情報: https://creativecommons.org/licenses/by-nc-sa/4.0/
出現コレクション:Vol.66 (2020)

このアイテムのファイル:

ファイル 記述 サイズフォーマット
FksmJMedSci_66_p148.pdf294.94 kBAdobe PDFダウンロード

このリポジトリに保管されているアイテムは、他に指定されている場合を除き、著作権により保護されています。

 

DSpace Software Copyright © 2002-2006 MIT and Hewlett-Packard